Author: Gautam R, Jachak SM, Saklani A.
Affiliation: Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER), Sector- 67, SAS Nagar, Mohali- 160062 (Punjab), India.
Conference/Journal: J Ethnopharmacol.
Date published: 2010 Nov 9
Other:
Word Count: 239
ETHNOPHARMACOLOGICAL RELEVANCE: Ajuga bracteosa Wall Ex Benth. (Labiateae) is described in Ayurveda for the treatment of rheumatism, gout, palsy and amenorrhea.
AIM OF THE STUDY: The aim of present investigation is to study anti-inflammatory activity of A. bracteosa, to understand possible mechanism of action and to identify the constituents responsible for its activity.
MATERIALS AND METHODS: The anti-inflammatory activity of 70% ethanolic extract was evaluated in TPA-induced mouse ear edema assay and in vitro cyclooxygenase (COX)-1 and COX-2 inhibitory activity was determined using EIA kits employing appropriate reference standards. Aajugarin I, lupulin A, withaferin A, reptoside and 6-deoxyharpagide were isolated from 70% ethanolic extract by silica gel column chromatography.
RESULTS: The 70% ethanol extract of whole plants of A. bracteosa showed a significant (p<0.05) and dose-dependent anti-inflammatory activity in an acute inflammation model at the dose of 0.5 and 1.0mg/ear. The extract also exhibited a strong in vitro COX-1 and COX-2 inhibitory activity at 25 and 50μg/mL concentration. Among the isolated compounds 6-deoxyharpagide exhibited highest COX-2 inhibition while rest of the compounds exhibited weak to moderate COX-1 and COX-2 inhibition at 30μM concentration.
CONCLUSION: The results suggest that the 70% ethanol extract of A. bracteosa possesses promising anti-inflammatory activity, which is possibly mediated through inhibition of COX-1 and COX-2 enzymes. The isolated constituents could be responsible in-part for its anti-inflammatory and COX inhibitory activity. The study supports traditional use of A. bracteosa for inflammatory diseases.
Copyright © 2010. Published by Elsevier Ireland Ltd.